Please login to read the full article.
Scrip Regulatory Affairs
New US bill introduced to tackle pay-for-delay settlements between drug makers
22 February 2012
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US user fee bill advances in Senate; House session postponed
- FTC: authorised generics benefit US consumers, but sometimes used as threat to competitors
- US Senate Judiciary Committee approves bill to limit pay-for-delay settlements
- Congressional analysis: Pay-for-delay ban would save US taxpayers $4.8B over 10 years
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
